dehydroevodiamine has been researched along with dinoprostone in 2 studies
| Studies (dehydroevodiamine) | Trials (dehydroevodiamine) | Recent Studies (post-2010) (dehydroevodiamine) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 48 | 1 | 18 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | dehydroevodiamine (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DA; Canning, MT; Galvin, JW; Nay, SL; Peña, AV; Yarosh, DB | 1 |
| Ahn, KS; Jung, SH; Kim, YS; Noh, EJ; Shin, EM | 1 |
1 trial(s) available for dehydroevodiamine and dinoprostone
| Article | Year |
|---|---|
Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine.
Topics: Administration, Cutaneous; Adult; Alkaloids; Anti-Inflammatory Agents; Biomimetics; Cell Line; Dinoprostone; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Erythema; Evodia; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; Indole Alkaloids; Keratinocytes; Middle Aged; Nicotinic Acids; Nitric Oxide; Plant Extracts; Quinazolines; Skin; Time Factors; Ultraviolet Rays | 2006 |
1 other study(ies) available for dehydroevodiamine and dinoprostone
| Article | Year |
|---|---|
Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-kappaB activation in RAW 264.7 macrophages.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Electrophoretic Mobility Shift Assay; Enzyme Induction; Gene Expression Regulation, Enzymologic; Lipopolysaccharides; Macrophages; Mice; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2006 |